The 2026 IPO pipeline is unlike anything the public markets have seen in a generation. Five private companies — SpaceX, OpenAI, Anthropic, Stripe, and Databricks — collectively represent more than $3 trillion in private market value and are at various stages of the path to public listing. If the pipeline executes, US IPO volume in 2026 could approach or exceed $100–150 billion, multiples of the entire 2025 market. For accredited investors who want pre-IPO exposure, the window is closing on some of these names faster than most expect.

This guide summarizes the current status, valuation, and IPO timeline for each company as of June 2026 — with what's confirmed, what's speculative, and what pre-IPO access still looks like for each.

SpaceX — Status: S-1 Filed, Roadshow Imminent

Current valuation: ~$1.75 trillion (IPO target) Last private valuation: ~$350 billion (2025 tender offer) IPO exchange: Nasdaq (ticker: SPCX expected)

SpaceX is the most consequential IPO in this pipeline by a wide margin. SpaceX filed confidentially in April 2026 (internally codenamed "Project Apex"), targeting a $1.75 trillion valuation and a $75 billion+ raise — which would surpass Saudi Aramco's $29.4 billion 2019 record as the largest IPO in history. The S-1 is public and Goldman Sachs is leading a 21-bank syndicate, with the roadshow reportedly beginning around June 4, 2026.

The offering includes a 30 percent retail allocation, which would be unusual for an IPO of this scale and signals an intentional effort to create broad public ownership of the company.

What this means for pre-IPO investors: At a $1.75 trillion IPO target, the entry price for any SPV or secondary purchase made at 2025 tender offer prices (~$350B valuation) would represent a roughly 5x valuation step-up to IPO — if the offering prices as targeted. Secondary market prices have likely already repriced significantly upward in anticipation. Anyone still seeking SpaceX exposure pre-IPO is effectively buying at or near IPO valuation, with minimal upside to the listing price and full lock-up risk until shares are freely tradeable.

OpenAI — Status: Pre-Filing, Late 2026 / 2027 Target

Current valuation: $852 billion (March 2026 funding round) IPO target valuation: ~$1 trillion Key financial data: ~$25 billion annualized revenue; projected $14 billion loss in 2026; not expected to be profitable until 2029–2030

OpenAI is generating $25 billion in annualized revenue at an $852 billion private valuation but has no filed S-1 as of mid-2026. CFO Sarah Friar has flagged late 2026 or 2027 as the most likely listing window.

OpenAI investors have reason to doubt the 2026 timeline. The company missed its own revenue targets recently and is still in a court battle with Elon Musk. CFO Sarah Friar has cautioned that OpenAI isn't ready to be a public company.

The structural complication for OpenAI's IPO is its unusual corporate governance: it is converting from a nonprofit-controlled structure to a public benefit corporation (PBC), a process that involves legal and regulatory steps that add timeline uncertainty. The conversion was announced in 2025 but has not yet been completed.

What this means for pre-IPO investors: OpenAI secondary shares and SPVs represent a legitimate 2026–2027 pre-IPO opportunity — but with meaningful timeline risk. At an $852 billion valuation, you're already pricing in significant AI market dominance. Investors entering at secondary market prices should understand they may be waiting 12–18 months or more for a liquidity event.

Anthropic — Status: In Discussion, Q4 2026 Target

Current valuation: ~$900 billion (in-discussion funding round) Annualized revenue: ~$44 billion run rate (May 2026 estimate) Key underwriters in discussion: Goldman Sachs, JPMorgan, Morgan Stanley

Anthropic has crossed $30 billion in annualized revenue on 1,400% year-over-year growth and is in talks to raise $50 billion at a $900 billion valuation. An IPO as early as October 2026 is in active discussion, with the raise expected to exceed $60 billion.

Anthropic is targeting a public listing as soon as October 2026. The company has engaged Wilson Sonsini Goodrich & Rosati — Google and LinkedIn's IPO counsel — for legal preparation.

Anthropic's IPO story centers on enterprise AI for regulated industries — healthcare, finance, legal — where accuracy and safety requirements favor Claude over competitors. The revenue trajectory is extraordinary, but the valuation implies that Anthropic becomes one of the most valuable companies in the world at a stage where its moat is still being defined by a competitive AI landscape that includes OpenAI, Google DeepMind, and Meta.

What this means for pre-IPO investors: Anthropic shares circulate on secondary platforms, but availability is limited and ROFR provisions can complicate transactions. An SPV structure allows a GP to negotiate a block purchase and distribute exposure to multiple LPs cleanly. At a $900 billion target valuation, the math on secondary market entry is similar to OpenAI — you're buying near the expected IPO price, not materially below it.

Stripe — Status: No Timeline, Founders Deprioritizing IPO

Current valuation: $159 billion (February 2026 tender offer) 2025 Net Revenue: ~$5.84 billion 2024 Free Cash Flow: ~$2.2 billion IPO Timeline: No confirmed date

Stripe is the contrarian play on this list. While SpaceX, OpenAI, and Anthropic are sprinting toward public markets, Stripe's co-founders Patrick and John Collison have repeatedly stated they are in no rush. An IPO would be "a solution in search of a problem" given the company is self-funding, profitable, and has no capital need that a public offering would solve.

Stripe's business is fundamentally different from the AI names in this pipeline: it is profitable, cash flow generative, and growing on a durable payments infrastructure flywheel rather than a speculative AI revenue ramp. The $159 billion valuation reflects that durability — but it also means there's no "growth multiple expansion" story driving the IPO urgency.

The most likely Stripe IPO catalyst would be employee liquidity pressure (Stripe has a large, long-tenured workforce with accumulated equity), or a strategic decision by the Collisons to use public currency for M&A. Neither is imminent.

What this means for pre-IPO investors: Stripe is the most fundamentally sound business in this cohort, but also the one with the least IPO urgency. Secondary market access exists but at a premium to the $159 billion tender offer price. An investor buying Stripe pre-IPO today should plan for a 2027–2028+ exit at the earliest — and be comfortable with the possibility that no IPO happens at all.

Databricks — Status: Profitable, H2 2026 Filing Expected

Current valuation: $134 billion (early 2026 funding round) 2025 Revenue: ~$5.4 billion (65% YoY growth) Profitability: Positive free cash flow; net retention rate above 140%

Databricks is the only profitable company in the AI IPO pipeline, with $5.4 billion in annualized revenue growing 65%, positive free cash flow, and a net retention rate above 140%. No S-1 has been filed as of May 2026. Analysts expect an H2 2026 filing.

Databricks' differentiation in this cohort is its unit economics. It generates real profits on its data intelligence platform, making it fundamentally more comparable to Snowflake or Palantir at IPO than to OpenAI or Anthropic — which are burning capital aggressively. The CFO has indicated Databricks is "ready when it decides" without committing to a fixed 2026 date.

What this means for pre-IPO investors: Databricks secondary access is available through platforms like Hiive and Forge. At a $134 billion valuation with real revenue and profitability, the valuation is easier to underwrite than the AI pure-plays. The IPO is likely but not yet filed — secondary investors have a window that will narrow quickly once the S-1 drops.

The Pre-IPO Access Question: Who Can Still Get In?

With most of these companies already valued in the hundreds of billions, the economic argument for pre-IPO exposure has shifted. You're no longer buying early-stage risk at a steep discount to a hypothetical future valuation — you're buying at or near expected IPO price, accepting illiquidity risk in exchange for potentially buying slightly below the public offering price.

The question is: is the illiquidity premium worth it?

For companies where the private valuation is already close to the anticipated IPO price (OpenAI, Anthropic), the pre-IPO premium is largely gone. For SpaceX, the valuation step-up from 2025 tender prices to IPO is substantial — but secondary prices have already moved significantly higher in anticipation.

How Accredited Investors Access These Companies Pre-IPO

For each company, the access mechanisms are the same:

Secondary market platforms: Hiive, Forge Global, and Nasdaq Private Market list available lots from employee and early investor sellers. Minimums are typically $100,000–$500,000. All require verified accredited investor status.

SPVs: A GP negotiates a secondary block purchase and syndicates access to LPs at lower minimums ($25,000–$100,000). SPVs are the most common access mechanism for individual accredited investors who can't reach secondary market minimums alone.

Funds with exposure: The ARK Venture Fund (ARKVX) holds SpaceX, OpenAI, and Anthropic. Destiny Tech100 (DXYZ) holds all five names but trades at a significant premium to NAV on NYSE.

Under FinCEN's January 2026 AML/KYC rules, all SPV and fund administrators must verify accredited investor status through documentation — self-certification is no longer sufficient for compliant onboarding.

What to Watch: Key Catalysts by Company

SpaceX: Roadshow execution and pricing date (expected June 2026). The SPCX opening trade will set the tone for the entire 2026 IPO market.

OpenAI: S-1 filing (expected Q3 2026 if 2026 listing stays on track). Revenue trajectory relative to the $852B valuation will be the critical data point.

Anthropic: Additional primary funding round above $300B valuation threshold would signal IPO deferral. Quarterly revenue crossing $10B annualized run rate is the green light for an October listing.

Stripe: Any signal from the Collisons — conference remarks, employee tender offer structure, banking mandates — that shifts the IPO from "eventually" to "actively planning."

Databricks: S-1 filing is the trigger. Once filed, secondary market pricing will move quickly. Watch for the filing in H2 2026.

Where Allocations Fits In

For GPs building SPVs to syndicate pre-IPO access to any of these companies, Allocations provides the formation, compliance, and LP management infrastructure. The platform handles KYC/AML verification under FinCEN's 2026 rules, subscription documents, cap table tracking, and K-1 administration — all at a flat fee with no carry clip.

As these companies move through their IPO processes, the pre-IPO window for SPV formation narrows. Lock-up periods post-IPO (typically 180 days) mean that even investors who hold shares at listing cannot sell immediately. The time to structure vehicles is before the S-1 drops, not after.

Frequently Asked Questions

Which of these companies will IPO first in 2026? Based on current filing status, SpaceX is furthest along with an S-1 filed and roadshow underway as of June 2026. Anthropic is targeting Q4 2026. OpenAI is most likely 2027 based on CFO guidance. Databricks and Stripe have no confirmed timelines.

Can retail investors buy SpaceX, OpenAI, or Anthropic shares before the IPO? No — not through primary channels. Retail investors can access Destiny Tech100 (DXYZ) on NYSE, which holds all of these names, but it typically trades at a significant premium to NAV. Direct pre-IPO access requires verified accredited investor status.

What happens to my SPV investment when the company goes public? The SPV's shares become publicly traded after the IPO lock-up period (typically 180 days). The GP then distributes shares or sale proceeds to LPs based on the SPV's operating agreement. Until the lock-up expires, your capital remains illiquid even after the company is technically "public."

Is it too late to get meaningful upside from pre-IPO investing in these names? For most of these companies, the substantial pre-IPO discount has already compressed. Secondary market prices reflect anticipated IPO valuations. The remaining upside argument is that the IPO will price above current secondary market levels — which is possible but not guaranteed, and carries liquidity risk in the interim.